Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R01AR073938 | B cell costimulatory signals in the pathogenesis of SLE | 1 | 2023 |
| R01CA228135 | Mechanisms of enhancer regulation in leukemia | 1 | 2023 |
| R01CA233490 | Genetic and Epigenetic Biomarkers for B-cell Lymphoma | 1 | 2023 |
| R01CA235026 | Integration of germline and tumor genomes in CLL | 1 | 2023 |
| R01DE028282 | Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer | 1 | 2023 |
| R01DK121227 | Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure | 1 | 2023 |
| R01GM130791 | Leveraging common genetic variation to reduce misclassification of non-diseased individuals and unnecessary health care utilization attributable to surrogate biomarkers | 1 | 2023 |
| R01HD098389 | Anti-inflammatory drug target to reduce adverse pregnancy outcomes. | 1 | 2023 |
| R01HG010492 | Epigenomic profiling of complex tissues with single-cell CUT&RUN | 1 | 2023 |
| R01HG011239 | Mapping gene-by-environment interactions using multiplexed single cell RNA-sequencing | 1 | 2023 |
| R01HL130261 | HIPPO Signaling in Pulmonary Arterial Hypertension | 1 | 2023 |
| R01HL144843 | Structure function relationships from deep mutational scanning in human cardiomyopathy | 1 | 2023 |
| R01HL147586 | Role of miR125 in pulmonary hypertension secondary to interstitial lung disease | 1 | 2023 |
| R01HL150638 | GATA-6 in pulmonary arterial hypertension | 1 | 2023 |
| R01HL152677 | Macrophage driven, profibrotic adrenergic nerve remodeling in SSc-ILD | 1 | 2023 |
| R01NS106950 | Genomics of Intracerebral Hemorrhage and its Causes | 1 | 2023 |
| R35CA220481 | Molecular and immunologic evolution of melanomas from pre-neoplastic lesions | 1 | 2023 |
| R35GM131770 | Pharmacogenetics to improve drug therapy | 1 | 2023 |
| R35HG010692 | Rapid Evolution of Genomic Architecture and Multi-omics Traits | 1 | 2023 |
| R35HL135795 | Therapeutic Implications of Molecular Defects in Bone Marrow Failure | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=27